CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.
作者信息
Parker Helen, McIver-Brown Neil Robert, Davis Zadie A, Parry Marina, Rose-Zerilli Matthew J J, Xochelli Aliki, Gibson Jane, Walewska Renata, Strefford Jonathan C, Oscier David G
机构信息
Cancer Genomics, Academic Unit for Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
出版信息
Blood Adv. 2018 May 22;2(10):1116-1119. doi: 10.1182/bloodadvances.2018019760.
Abstract
摘要
相似文献
1
CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.CBL-MZ并非单一生物实体：来自基因组分析和长期临床随访的证据。
Blood Adv. 2018 May 22;2(10):1116-1119. doi: 10.1182/bloodadvances.2018019760.
2
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).在一系列边缘区起源的克隆性B细胞淋巴细胞增多症（CBL-MZ）中检测L265P MYD-88突变。
Hematol Oncol. 2017 Dec;35(4):542-547. doi: 10.1002/hon.2361. Epub 2016 Oct 13.
3
Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?表现为边缘区来源免疫表型特征的克隆性 B 细胞淋巴细胞增多症：这是一个独特的实体吗？
Blood. 2014 Feb 20;123(8):1199-206. doi: 10.1182/blood-2013-07-515155. Epub 2013 Dec 3.
4
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features.具有边缘区特征的克隆性B细胞淋巴细胞增多症中信号通路基因的分子病变
Br J Haematol. 2014 Dec;167(5):718-20. doi: 10.1111/bjh.13052. Epub 2014 Aug 4.
5
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.CD5 表达鉴定出具有更高淋巴细胞增多的脾边缘区淋巴瘤亚群：24 例临床病理、细胞遗传学和分子研究。
Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.
6
Clonal B-cell lymphocytosis: a new member?克隆性B细胞淋巴细胞增多症：一个新成员？
Blood. 2014 Feb 20;123(8):1118-9. doi: 10.1182/blood-2013-12-543330.
7
Splenic marginal zone lymphoma: hydra with many heads?脾边缘区淋巴瘤：多头水螅？
Haematologica. 2010 Apr;95(4):534-7. doi: 10.3324/haematol.2009.021576.
8
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells.对非脾脏边缘区淋巴瘤（MZL）的基因组分析表明，结内和结外 MZL 之间存在相似性，并支持它们来源于记忆 B 细胞。
Br J Haematol. 2011 Nov;155(3):362-5. doi: 10.1111/j.1365-2141.2011.08841.x. Epub 2011 Aug 25.
9
Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.全基因组DNA分析鉴定边缘区淋巴瘤中的克隆异质性。
Br J Haematol. 2014 Mar;164(6):896-9. doi: 10.1111/bjh.12688. Epub 2013 Dec 11.
10
Clonal B-cell lymphocytosis of marginal zone origin.边缘区起源的克隆性B淋巴细胞增多症
Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):77-83. doi: 10.1016/j.beha.2016.08.028. Epub 2016 Nov 4.
引用本文的文献
1
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.脾边缘区淋巴瘤的基因组和分子图谱、生物学及临床意义
Explor Target Antitumor Ther. 2024;5(4):877-901. doi: 10.37349/etat.2024.00253. Epub 2024 Jul 23.
2
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.脾脏边缘区淋巴瘤体细胞突变的系统评价
Sci Rep. 2019 Jul 18;9(1):10444. doi: 10.1038/s41598-019-46906-1.
本文引用的文献
1
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations.高通量测序检测结外边缘区淋巴瘤中复发的 BRAF 突变。
Leukemia. 2018 Nov;32(11):2412-2426. doi: 10.1038/s41375-018-0082-4. Epub 2018 Feb 28.
2
Exome sequencing identifies recurrent alterations and the absence of , and mutations in splenic diffuse red pulp small B-cell lymphoma.外显子组测序鉴定出脾弥漫性红髓小 B 细胞淋巴瘤中反复出现的改变，以及 和 突变的缺失。
Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.
3
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.肿瘤坏死因子α诱导蛋白3（TNFAIP3）失活与黏膜相关淋巴组织淋巴瘤中免疫球蛋白重链可变区4-34使用偏向之间的显著关联。
J Pathol. 2017 Sep;243(1):3-8. doi: 10.1002/path.4933. Epub 2017 Aug 7.
4
Clonal B-cell lymphocytosis of marginal zone origin.边缘区起源的克隆性B淋巴细胞增多症
Best Pract Res Clin Haematol. 2017 Mar-Jun;30(1-2):77-83. doi: 10.1016/j.beha.2016.08.028. Epub 2016 Nov 4.
5
Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.脾弥漫性红髓小B细胞淋巴瘤表现出细胞周期蛋白D3表达增加以及CCND3基因反复突变。
Blood. 2017 Feb 23;129(8):1042-1045. doi: 10.1182/blood-2016-11-751024. Epub 2017 Jan 9.
6
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).在一系列边缘区起源的克隆性B细胞淋巴细胞增多症（CBL-MZ）中检测L265P MYD-88突变。
Hematol Oncol. 2017 Dec;35(4):542-547. doi: 10.1002/hon.2361. Epub 2016 Oct 13.
7
Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.脾弥漫性红髓淋巴瘤在B细胞恶性肿瘤中具有独特的体细胞突变模式。
Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27.
8
Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.非典型毛细胞白血病和毛细胞白血病变异型中激活型MAP2K1突变的检测
Leuk Lymphoma. 2017 Jan;58(1):233-236. doi: 10.1080/10428194.2016.1185786. Epub 2016 May 31.
9
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.脾脏弥漫性红髓小B细胞淋巴瘤中的NOTCH1、TP53和MAP2K1突变与疾病进展相关。
Am J Surg Pathol. 2016 Feb;40(2):192-201. doi: 10.1097/PAS.0000000000000523.
10
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.脾边缘区淋巴瘤的遗传学与预后评估：深度测序的启示
Clin Cancer Res. 2015 Sep 15;21(18):4174-4183. doi: 10.1158/1078-0432.CCR-14-2759. Epub 2015 Mar 16.
Zotero 插件